journal.pone.0004725.pdf (287.26 kB)
Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin.
journal contribution
posted on 2012-10-24, 08:59 authored by P. A. Jansen, D. Rodijk-Olthuis, Edward J. Hollox, M. Kamsteeg, G. S. Tjabringa, G. J. de Jongh, I. M. van Vlijmen-Willems, J. G. Bergboer, M. M. van Rossum, E. M. de Jong, M. den Heijer, A. W. Evers, M. Bergers, J. A. Armour, P. L. Zeeuwen, J. SchalkwijkPrevious studies have extensively documented antimicrobial and chemotactic activities of beta-defensins. Human beta-defensin-2 (hBD-2) is strongly expressed in lesional psoriatic epidermis, and recently we have shown that high beta-defensin genomic copy number is associated with psoriasis susceptibility. It is not known, however, if biologically and pathophysiologically relevant concentrations of hBD-2 protein are present in vivo, which could support an antimicrobial and proinflammatory role of beta-defensins in lesional psoriatic epidermis.
History
Citation
PLoS ONE, 2009, 4 (3), pp. e4725-e4725Published in
PLoS ONEissn
1932-6203eissn
1932-6203Available date
2012-10-24Publisher DOI
Publisher version
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004725Language
engAdministrator link
Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC